Viselner, Gisela
Farina, Lisa
Lucev, Federica
Turpini, Elena
Lungarotti, Luca
Bacila, Ana
Iannalfi, Alberto
D’Ippolito, Emma
Vischioni, Barbara
Ronchi, Sara
Marchioni, Enrico
Valvo, Francesca
Bastianello, Stefano
Preda, Lorenzo http://orcid.org/0000-0002-5479-2766
Article History
Received: 18 June 2019
Accepted: 19 August 2019
First Online: 23 September 2019
Ethics approval and consent to participate
: All subjects considered in this study consented to participate to the trial “Confronto tra l’impiego della tomografia ad emissioni di positroni (PET) e la risonanza magnetica ad alto campo (RM 3.0 T) nella definizione del volume bersaglio e della risposta precoce al trattamento in pazienti sottoposti ad adroterapia per neoplasie solide” (original title in Italian language)—Positron emission tomography (PET) versus high field magnetic resonance (RM 3T) comparison in target volume definition and early response to hadrontherapy in solid neoplasms patients. The mentioned study has been approved by European Institute of Oncology Ethics Committee on February, 17<sup>th</sup>, 2010 with the code IEO/CNAO/S512/110.
: All images contained in the manuscript are anonymous. No personal data can be drawn from images attached.
: The authors declare that they have no competing interests.